PathAI Closes $165M Series D to Scale AI Pathology Platform Globally

<div class="space-y-8"> <div class="bg-gradient-to-br from-green-900/20 to-emerald-900/20 rounded-2xl p-8 border border-green-700/30"> <h2 class="text-2xl font-bold text-white mb-4">Funding Round Details</h2> <p class="text-gray-100 text-lg leading-relaxed"> PathAI announced a <strong class="text-white">$165 million Series D</strong> financing led by <strong class="text-white">Tiger Global Management</strong> with participation from existing investors General Catalyst, Fidelity, and Merck Global Health Innovation Fund. </p> </div> <div class="grid grid-cols-1 md:grid-cols-2 gap-6 my-10"> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Funding Amount</h4> <div class="text-3xl font-bold text-green-400 mb-1">$165M</div> <p class="text-sm text-gray-400">Series D Round</p> </div> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Valuation</h4> <div class="text-3xl font-bold text-blue-400 mb-1">$1.2B</div> <p class="text-sm text-gray-400">Post-money unicorn status</p> </div> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Total Raised</h4> <div class="text-3xl font-bold text-purple-400 mb-1">$405M</div> <p class="text-sm text-gray-400">Since 2016</p> </div> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Annual Volume</h4> <div class="text-3xl font-bold text-orange-400 mb-1">5M+</div> <p class="text-sm text-gray-400">Tissue samples analyzed</p> </div> </div> <div class="my-12"> <h2 class="text-3xl font-bold text-white mb-6 pb-4 border-b border-gray-800">Platform Capabilities</h2> <div class="space-y-4"> <div class="bg-gradient-to-r from-blue-900/20 to-cyan-900/20 rounded-lg p-5 border-l-4 border-blue-500"> <h4 class="text-lg font-bold text-white mb-2">Cancer Detection</h4> <p class="text-gray-300">96.5% concordance with expert pathologists for 15+ cancer types</p> </div> <div class="bg-gradient-to-r from-purple-900/20 to-pink-900/20 rounded-lg p-5 border-l-4 border-purple-500"> <h4 class="text-lg font-bold text-white mb-2">Biomarker Quantification</h4> <p class="text-gray-300">Automated PD-L1, HER2, Ki-67 scoring for treatment selection</p> </div> <div class="bg-gradient-to-r from-green-900/20 to-emerald-900/20 rounded-lg p-5 border-l-4 border-green-500"> <h4 class="text-lg font-bold text-white mb-2">Prognostic Scoring</h4> <p class="text-gray-300">Survival prediction models trained on 500K+ annotated cases</p> </div> <div class="bg-gradient-to-r from-orange-900/20 to-red-900/20 rounded-lg p-5 border-l-4 border-orange-500"> <h4 class="text-lg font-bold text-white mb-2">Workflow Integration</h4> <p class="text-gray-300">Direct integration with Leica, Philips, Roche digital pathology scanners</p> </div> </div> </div> <div class="my-12"> <h2 class="text-3xl font-bold text-white mb-6 pb-4 border-b border-gray-800">Clinical Adoption</h2> <div class="grid grid-cols-1 md:grid-cols-2 gap-6"> <div class="bg-gradient-to-br from-blue-900/20 to-cyan-900/20 rounded-xl p-6 border border-blue-700/30"> <h4 class="text-xl font-bold text-white mb-3">Laboratory Partners</h4> <p class="text-gray-100 text-lg mb-2"><strong class="text-white">60+</strong> partners</p> <p class="text-gray-300 text-sm">Hospital pathology departments and reference labs</p> </div> <div class="bg-gradient-to-br from-green-900/20 to-emerald-900/20 rounded-xl p-6 border border-green-700/30"> <h4 class="text-xl font-bold text-white mb-3">Pharma Partnerships</h4> <p class="text-gray-100 text-sm">Bristol Myers Squibb, Novartis, AstraZeneca</p> <p class="text-gray-300 text-sm">For clinical trial pathology</p> </div> <div class="bg-gradient-to-br from-purple-900/20 to-pink-900/20 rounded-xl p-6 border border-purple-700/30"> <h4 class="text-xl font-bold text-white mb-3">Turnaround Time</h4> <p class="text-gray-100 text-lg mb-2"><strong class="text-white">24 hours</strong></p> <p class="text-gray-300 text-sm">vs. 3-5 days traditional pathology</p> </div> <div class="bg-gradient-to-br from-orange-900/20 to-red-900/20 rounded-xl p-6 border border-orange-700/30"> <h4 class="text-xl font-bold text-white mb-3">Regulatory Status</h4> <p class="text-gray-100 text-sm mb-2">3 FDA De Novo applications pending</p> <p class="text-gray-300 text-sm">CE Mark approved for EU</p> </div> </div> </div> <div class="bg-gradient-to-br from-orange-900/30 to-red-900/30 rounded-2xl p-8 border border-orange-700/50 my-12"> <h3 class="text-2xl font-bold text-white mb-4">Market Opportunity</h3> <p class="text-gray-100 text-lg leading-relaxed"> Digital pathology AI market projected to reach <strong class="text-white">$2.7B by 2028</strong>, driven by pathologist workforce shortage (<strong class="text-white">40% deficit projected by 2030</strong>) and demand for precision medicine biomarkers. </p> </div> <div class="border-t border-gray-800 pt-6"> <p class="text-sm text-gray-500 italic"> <strong>Source:</strong> PathAI, Tiger Global, Digital Pathology Association, Archives of Pathology & Laboratory Medicine </p> </div> </div>